Hem › Juvenil myelomonocyt leukemi › Illinois › Chicago
Kliniska studier för Juvenil myelomonocyt leukemi i Chicago, IL
3 studier för Juvenil myelomonocyt leukemi söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RekryterarFas 1/2
- Lurie Children's Hospital of Chicago, Chicago
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RekryterarFas 1
- Lurie Children's Hospital-Chicago, Chicago
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Juvenil myelomonocyt leukemi-studier i andra städer
- Minneapolis, MN4 studier
- Philadelphia, PA4 studier
- Boston, MA3 studier
- Atlanta, GA3 studier
- Memphis, TN3 studier
- New York City, NY3 studier
- Indianapolis, IN3 studier
- Washington, DC3 studier
- Cincinnati, OH3 studier
- Ann Arbor, MI3 studier
- San Francisco, CA3 studier
- Seattle, WA3 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer59 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Lungcancer41 studier
- Övervikt41 studier
- Äggstockscancer36 studier
- Kolorektal cancer34 studier
- Stroke34 studier
- Hjärtsvikt31 studier
- Övervikt29 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.